6DHR

NMR Solution structure of Rivi3

Summary for 6DHR

• Entry DOI: 10.2210/pdb6dhr/pdb
• NMR Information: BMRB: 30470
• Descriptor: Rivi3 (1 entity in total)
• Functional Keywords: cyclotide cyclic peptide, plant protein
• Biological source: Rinorea virgata
• Total number of polymer chains: 1
• Total formula weight: 3139.78

Authors

Harvey, P.J.,Craik, D.J. (deposition date: 2018-05-21, release date: 2019-04-17, Last modification date: 2024-10-09)

Primary citation

Niyomploy, P.,Chan, L.Y.,Harvey, P.J.,Poth, A.G.,Colgrave, M.L.,Craik, D.J.
Discovery and Characterization of Cyclotides from Rinorea Species.
J. Nat. Prod., 81:2512-2520, 2018

PubMed Abstract: Cyclotides are macrocyclic cystine-knotted peptides most commonly found in the Violaceae plant family. Although Rinorea is the second-largest genera within the Violaceae family, few studies have examined whether or not they contain cyclotides. To further our understanding of cyclotide diversity and evolution, we examined the cyclotide content of two Rinorea species found in Southeast Asia: R. virgata and R. bengalensis. Seven cyclotides were isolated from R. virgata (named Rivi1-7), and a known cyclotide (cT10) was found in R. bengalensis. Loops 2, 5, and 6 of Rivi1-4 contained sequences not previously seen in corresponding loops of known cyclotides, thereby expanding our understanding of the diversity of cyclotides. In addition, the sequence of loop 2 of Rivi3 and Rivi4 were identical to some related noncyclic "acyclotides" from the Poaceae plant family. As only acyclotides, but not cyclotides, have been reported in monocotyledons thus far, our findings support an evolutionary link between monocotyledon-derived ancestral cyclotide precursors and dicotyledon-derived cyclotides. Furthermore, Rivi2 and Rivi3 had comparable cytotoxic activities to the most cytotoxic cyclotide known to date: cycloviolacin O2 from Viola odorata; yet, unlike cycloviolacin O2, they did not show hemolytic activity. Therefore, these cyclotides represent novel scaffolds for use in future anticancer drug design.

PubMed: 30387611
DOI: 10.1021/acs.jnatprod.8b00572

Experimental method

SOLUTION NMR